Please Wait
Applying Filters...
menu
    • menu
    M2i Group-PSE
    News
    M2i invents the biocontrol of tomorrow

    22 Mar 2024

    // USINGNOUVELLE

    Bayer To Distribute Biological Crop Protection Solutions From M2i Group

    31 Jan 2023

    // PRESS RELEASE

    M2I Life Sciences strengthens its CSR to attract funds and talents

    07 Dec 2022

    // BUSINESS LESECHOS

    Data Compilation
    #PharmaFlow

    m2i group

    Contact Supplier

    Website

    Antibody Engineering

    Not Confirmed

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    https://www.youtube.com/embed/RkeJp2wSz7U
    Menu

    M2i Group

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    Key Products KEY PRODUCTS

    SERVICES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital content

    Explore the latest content creation from this company

    CORPORATE CONTENT #SupplierSpotlight

    Product List 2024

    read-more

      https://www.pharmacompass.com/pdf/party/content/m2i-group-party-content-6779.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    Corporate Presentation

    read-more

      https://www.pharmacompass.com/pdf/party/content/m2i-group-party-content-1647322624.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    GMP Certificate 2021

    read-more

      https://www.pharmacompass.com/pdf/party/content/m2i-group-party-content-1647325562.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    Approval of EVG Pheromone

    read-more

      https://www.pharmacompass.com/pdf/party/content/m2i-group-party-content-1647323101.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    M2i Biocontrol Catalogue 2020

    read-more

      https://www.pharmacompass.com/pdf/party/content/m2i-life-sciences-party-content-1611986692.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    NEWS #PharmaBuzz

    read-more
    read-more
    M2i invents the biocontrol of tomorrow
    M2i invents the biocontrol of tomorrow

    22 Mar 2024

    // USINGNOUVELLE

    https://www.usinenouvelle.com/article/m2i-le-biocontrole-de-demain.N2208274

    USINGNOUVELLE
    22 Mar 2024
    Share Share
    Bayer To Distribute Biological Crop Protection Solutions From M2i Group
    Bayer To Distribute Biological Crop Protection Solutions From M2i Group

    31 Jan 2023

    // PRESS RELEASE

    https://www.bayer.com/media/en-us/bayer-to-distribute-pheromone-based-biological-crop-protection-solutions-from-m2i-group/

    PRESS RELEASE
    31 Jan 2023
    Share Share
    M2I Life Sciences strengthens its CSR to attract funds and talents
    M2I Life Sciences strengthens its CSR to attract funds and talents

    07 Dec 2022

    // BUSINESS LESECHOS

    https://business.lesechos.fr/entrepreneurs/marketing-vente/0701921019129-m2i-life-sciences-renforce-sa-rse-pour-attirer-les-fonds-et-les-talents-348828.php

    BUSINESS LESECHOS
    07 Dec 2022
    Share Share
    M2I Continued Sustained Internal Growth 1Q 2022 With Activity Increased By +8.6%
    M2I Continued Sustained Internal Growth 1Q 2022 With Activity Increased By +8.6%

    05 Dec 2022

    // PRESS RELEASE

    https://www.pharmacompass.com/pdf/news/m2i-continued-sustained-internal-growth-1q-2022-with-activity-increased-by-86-32226.pdf

    PRESS RELEASE
    05 Dec 2022
    Share Share
    M2I - Acceleration Of Operational Profitability In H1 2022
    M2I - Acceleration Of Operational Profitability In H1 2022

    30 Sep 2022

    // PRESS RELEASE

    https://www.pharmacompass.com/pdf/news/m2i-acceleration-of-operational-profitability-in-h1-2022-90073.pdf

    PRESS RELEASE
    30 Sep 2022
    Share Share
    M2i - Organic growth of +12.3% in the 3rd quarter of 2022
    M2i - Organic growth of +12.3% in the 3rd quarter of 2022

    08 Sep 2022

    // PRESS RELEASE

    https://www.pharmacompass.com/pdf/news/m2i-organic-growth-of-123-in-the-3rd-quarter-of-2022-55524.pdf

    PRESS RELEASE
    08 Sep 2022
    Share Share
    Contact M2i Group and get a quotation

    M2i Group is a supplier offers 13 products (APIs, Excipients or Intermediates).

    Find a price of Anethole Trithione bulk offered by M2i Group

    Find a price of Aspirin Lysinate bulk offered by M2i Group

    Find a price of Betaxolol bulk offered by M2i Group

    Find a price of Cimetropium Bromide bulk offered by M2i Group

    Find a price of Diphenhydramine Methylsulfate bulk offered by M2i Group

    Find a price of Guaiacol bulk offered by M2i Group

    Find a price of Metopimazine bulk offered by M2i Group

    Find a price of Myrtecaine bulk offered by M2i Group

    Find a price of Myrtecaine Lauryl Sulfate bulk offered by M2i Group

    Find a price of Pinaverium Bromide bulk offered by M2i Group

    Find a price of Resorcinol bulk offered by M2i Group

    Find a price of Roflumilast bulk offered by M2i Group

    Find a price of Veratrole bulk offered by M2i Group